Athens Medical Centre (STU:ACS) Beneish M-Score: -2.46 (As of Jun. 25, 2026)


STU:ACS Athens Medical Centre SA STU:ACS
60 GF Score
Price €1.59
GF Value €1.93
! 8 Warning Signs
View Full Analysis

What is Athens Medical Centre Beneish M-Score?

Athens Medical Centre STU:ACS +0.63% 60 Beneish M-Score is -2.46 as of Jun. 25, 2026. GuruFocus rates STU:ACS with a GF Score™ of 60/100 and a GF Value™ of €1.93. The stock has 8 warning signs investors should review. Among 632 Healthcare Providers & Services companies, Athens Medical Centre ranks worse than 61.08% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.46 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Athens Medical Centre's Beneish M-Score or its related term are showing as below:

STU:ACS' s Beneish M-Score Range Over the Past 10 Years
Min: -2.93   Med: -2.65   Max: -2.02
Current: -2.46

During the past 13 years, the highest Beneish M-Score of Athens Medical Centre was -2.02. The lowest was -2.93. And the median was -2.65.


Athens Medical Centre Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Athens Medical Centre's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Athens Medical Centre Beneish M-Score Chart

Athens Medical Centre Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.78 -2.02 -2.10 -2.70 -2.46

Athens Medical Centre Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.10 0.00 -2.70 0.00 -2.46

STU:ACS vs HCA, THC, DVA: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, Athens Medical Centre's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Athens Medical Centre Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Athens Medical Centre's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Athens Medical Centre's Beneish M-Score falls into.


STU:ACS
60GF Score
Athens Medical Centre SA STU:ACS
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Athens Medical Centre Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Athens Medical Centre for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0649+0.528 * 1.1061+0.404 * 1.0866+0.892 * 1.0219+0.115 * 0.8913
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1385+4.679 * -0.018315-0.327 * 1.0732
=-2.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was €173.3 Mil.
Revenue was €275.8 Mil.
Gross Profit was €56.1 Mil.
Total Current Assets was €219.6 Mil.
Total Assets was €532.8 Mil.
Property, Plant and Equipment(Net PPE) was €299.3 Mil.
Depreciation, Depletion and Amortization(DDA) was €19.5 Mil.
Selling, General, & Admin. Expense(SGA) was €8.5 Mil.
Total Current Liabilities was €287.5 Mil.
Long-Term Debt & Capital Lease Obligation was €75.9 Mil.
Net Income was €-4.7 Mil.
Gross Profit was €0.0 Mil.
Cash Flow from Operations was €5.1 Mil.
Total Receivables was €159.3 Mil.
Revenue was €269.8 Mil.
Gross Profit was €60.8 Mil.
Total Current Assets was €191.9 Mil.
Total Assets was €495.9 Mil.
Property, Plant and Equipment(Net PPE) was €292.1 Mil.
Depreciation, Depletion and Amortization(DDA) was €16.8 Mil.
Selling, General, & Admin. Expense(SGA) was €7.3 Mil.
Total Current Liabilities was €230.8 Mil.
Long-Term Debt & Capital Lease Obligation was €84.5 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(173.318 / 275.752) / (159.264 / 269.845)
=0.628529 / 0.590205
=1.0649

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(60.763 / 269.845) / (56.138 / 275.752)
=0.225177 / 0.203581
=1.1061

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (219.606 + 299.323) / 532.783) / (1 - (191.869 + 292.123) / 495.858)
=0.026003 / 0.02393
=1.0866

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=275.752 / 269.845
=1.0219

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(16.804 / (16.804 + 292.123)) / (19.455 / (19.455 + 299.323))
=0.054395 / 0.06103
=0.8913

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(8.513 / 275.752) / (7.317 / 269.845)
=0.030872 / 0.027116
=1.1385

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((75.948 + 287.547) / 532.783) / ((84.478 + 230.757) / 495.858)
=0.682257 / 0.635736
=1.0732

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-4.67 - 0 - 5.088) / 532.783
=-0.018315

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Athens Medical Centre has a M-score of -2.46 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.46 mean?
Athens Medical Centre (STU:ACS) has a Beneish M-Score of -2.46 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Athens Medical Centre and its competitors. According to the industry distribution chart, Athens Medical Centre ranks #386 out of 632 companies in the Healthcare Providers & Services industry, placing it in the top 61.1%.
Is Athens Medical Centre's Beneish M-Score too high?
Athens Medical Centre's current Beneish M-Score is -2.46. Based on the distribution chart, Athens Medical Centre ranks #386 out of 632 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Athens Medical Centre has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Athens Medical Centre's Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Athens Medical Centre ranks #386 out of 632 companies for Beneish M-Score. This places Athens Medical Centre in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Athens Medical Centre and its competitors. Athens Medical Centre's current Beneish M-Score is -2.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athens Medical Centre stock overvalued right now?
Athens Medical Centre (STU:ACS) has a current Beneish M-Score of -2.46. The stock's GF Value™ is €1.93, compared to a current price of €1.59 — trading 17.9% below its estimated fair value. The current Beneish M-Score is -2.46. Athens Medical Centre's overall GF Score™ is 60/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Athens Medical Centre (STU:ACS), the current Beneish M-Score is -2.46 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Athens Medical Centre (STU:ACS) Overvalued in 2026?

Based on GuruFocus' analysis, Athens Medical Centre stock appears to be undervalued. The current stock price of €1.59 is trading 17.9% below its estimated GF Value™ of €1.93.

Key valuation signals for STU:ACS:

  • Beneish M-Score: -2.46
  • GF Value™: €1.93 vs. price of €1.59 (17.9% below fair value)
  • GF Score™: 60/100 with 8 warning signs

No single metric tells the full story. See the STU:ACS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Athens Medical Centre Business Description

Other Exchanges IATR:GreeceACS:Germany
Address 5-7 Distomou Street Maroussi, Athens, GRC, 15125
Athens Medical Centre SA engages in the provision of healthcare services. It includes medical research and methods of treatment, training, and selection of executives and staff on behalf of the hospitals and importation of medical tools, instruments, machinery, and automated devices for the hospitals. Its offering includes medical services in such specializations as pathology, cardiology, general surgery, plastic and vascular surgery, orthopedic, physiotherapy, ophthalmology, urology, neurosurgery, thoracic, pediatric, dermatology, endocrinology and stomatology. The company operates in Domestic healthcare service, Healthcare service provided abroad (Romania) and Sale of medical tools & sanitary/health equipment segment.
60GF Score

Get the complete analysis for STU:ACS

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.59
Price
€1.93
GF Value